One assignee leads the ranked field with 37 of the 101 records in scope, well ahead of fifth place at 7 records. The top 5 assignees combined account for 84.2% of all 101 records, and the top 10 reach 97.0%, so filing activity in this niche is concentrated among a small group rather than spread across many small filers. The 13-company ranking returned for this dataset is the complete list the data endpoint provides, not a top-50 or top-100 cut.

The core technical areas are hop oil extraction, enzymatic biotransformation of hop compounds, hop creep management, aroma retention during processing, dosing timing in the brew cycle, and beer loss reduction tied to hop solids. Classification data shows 80.2% of the 101 records carry a C12C brewing-of-beer classification, with fermentation science (C12P, 31.7%) and wine/fermented beverages (C12G, 17.8%) as the largest adjacent areas. Smaller but distinct clusters touch peptide chemistry and medicinal preparations, showing hop-derived compounds are occasionally claimed outside the beverage context entirely.

Filing peaked so far in 2019 at 22 records, and the 2021-to-2024 span — the last window that can be treated as complete — shows a further +14% increase. Years from 2025 onward appear lower in the raw trend, but publication typically lags filing by roughly 18 months, so those years are still filling in rather than showing an actual decline. Read the trend through 2024 as the reliable signal.

The two most-cited records, WO2020069100A1 and GB1576729A, each carry 8 citations, with three further records — US20210010038A1, WO2020069139A2 and US10961550B2 — all citing back to the same enzymatic-process family for modified hop products. This concentration means the most influential prior art in the field is not spread evenly; it sits on one specific enzymatic-modification lineage. Citation counts inside any searched corpus tend to favour older filings, so treat this as a map of influence rather than a ranking of current commercial value.

The thinnest classified areas — C07K peptides and proteins at 5.9% of records and A61K medicinal preparations at 3.0% — mark where hop-derived chemistry has barely been claimed outside conventional beverage use. Sub-areas such as ultrasound-assisted extract emulsification, in-line dosing-timing sensors, and hop creep enzyme deactivation methods also carry comparatively few records relative to the dense C12C brewing-process core. These branches sit adjacent to, rather than inside, the heavily filed enzymatic-modification cluster, which is where a narrower first claim is more likely to clear prior art.